product discontinuation — e.g. “Motive comerciale” (Romania)
Recent shortage history
Iceland: resolved 8 Sept 2026 (began 8 Sept 2026)
Iceland: resolved 5 Sept 2026 (began 5 Sept 2026)
Iceland: resolved 4 Sept 2026 (began 4 Sept 2026)
Iceland: resolved 30 Aug 2026 (began 30 Aug 2026)
Iceland: resolved 28 Aug 2026 (began 28 Aug 2026)
Iceland: resolved 26 Aug 2026 (began 26 Aug 2026)
Iceland: resolved 21 Aug 2026 (began 21 Aug 2026)
Iceland: resolved 9 Jul 2026 (began 24 Jun 2026)
Frequently asked questions
Is Omalizumabum currently in shortage?
Yes. As of the latest regulator updates, Omalizumabum has 1 active shortage notice across 1 country (Romania). Status is refreshed daily from official regulatory sources.
Why is Omalizumabum in shortage?
Regulators attribute the current Omalizumabum shortages to product discontinuation. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Omalizumabum shortage be resolved?
Regulator-estimated resolution dates currently range from 1 Sept 2026 to 1 Sept 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Omalizumabum shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Omalizumabum status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.